Walgreens Navigates a Mountain of Debt Following Takeover

Walgreens US9314271084

Although its shares have been delisted, the financial health of the former DAX competitor Walgreens remains a pertinent topic for investors. Recent disclosures have laid bare the significant debt burden the pharmacy chain is now carrying after its acquisition by the private equity firm Sycamore Partners. For former shareholders, this situation directly impacts the potential for additional payouts.

The financial structure following the August 28, 2025, privatization became clear with figures released on January 16, 2026. They reveal that Walgreens' total debt now stands at $13.33 billion. This liability stems directly from the financing of the $18.8 billion takeover, which was funded with 70.9% debt.

While such aggressive leverage is characteristic of private equity deals, it substantially limits the company's operational flexibility. Analysts note similarities with Sycamore Partners' previous acquisitions, referencing the restructuring of Staples and the bankruptcy of Nine West.

Implications for Former Shareholders

Investors who held shares until the delisting continue to have a stake in the company's fiscal stability. They received a guaranteed cash payment of $11.45 per share but also retain a Contingent Value Right (CVR).

This security entitles them to potential additional distributions of up to $3.00 per share, contingent on the sale or monetization of VillageMD assets. The newly revealed scale of the debt could influence strategic decisions regarding these assets, potentially reducing the likelihood of further payouts.

Austerity Measures Take Hold

The imperative to service heavy interest payments has triggered rigorous cost-cutting initiatives. Walgreens has already implemented specific austerity steps:

• Elimination of holiday pay premiums for employees ahead of Thanksgiving 2025.
• Dissolution of the entire corporate communications team.
• A planned closure of the Chicago corporate headquarters in 2026.

These actions underscore a management focus squarely fixed on generating cash flow for debt repayment.

The transformation from a publicly-traded blue-chip to a highly leveraged private entity is complete. Debt metrics will now be the primary factor dictating Walgreens' strategy and operational latitude throughout 2026.